CVE-2025-54573 json
CVAT vulnerable to email verification bypass by use of basic authentication
published last yr. modified 4mo ago also EUVD-2025-23169
- cvss
- 4.3
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 23%
- public exploits
- 0
- none known
Summary
CVAT is an open source interactive video and image annotation tool for computer vision. In versions 1.1.0 through 2.41.0, email verification was not enforced when using Basic HTTP Authentication. As a result, users could create accounts using fake email addresses and use the product as verified users. Additionally, the missing email verification check leaves the system open to bot signups and further usage. CVAT 2.42.0 and later versions contain a fix for the issue. CVAT Enterprise customers have a workaround available; those customers may disable registration to prevent this issue.
Patch / fix
Is CVE-2025-54573 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerCISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- last yr.
Exploit prediction
0.30% chance of exploitation in the next 30 days, higher than 23% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 4.3 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L |
| NVD | 3.1 | 6.5 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N |
Affected products
- cvat-ai cvat
Classification
- Weakness
-
- CWE-287 Improper Authentication
References
Sources
- CVE List CVE-2025-54573
- NVD CVE-2025-54573
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.